(Q34143728)

31 July 2017

1 reference

title

Update on anorexia and cachexia (English)

1 reference

31 July 2017

Florian Strasser

1

1 reference

31 July 2017

Eduardo D Bruera

series ordinal

2

1 reference

31 July 2017

publication date

1 June 2002

1 reference

Hematology / Oncology Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

589-617

1 reference

The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Clinical Symptoms and Length of Survival in Patients With Terminal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Clinical survival predictors in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Terminal cancer. duration and prediction of survival time

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Cachexia-anorexia-asthenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Autonomic failure in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A body image scale for use with cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Delirium at the end of life: critical issues in clinical practice and research

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Malnutrition and food intake in relation to quality of life in head and neck cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Terminal nutrition: framing the debate for the withdrawal of nutritional support in terminally ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Use of TPN in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

1 reference

7 January 2021

Metabolic interrelationships between liver and skeletal muscle in pathological states.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Biomedicine. Protein loss in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Leptin and the regulation of body weight in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Plasma concentration of total leptin and human lung-cancer-associated cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Afferent vagal modulation. Clinical studies of visceral sensory input

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Modulation of neurocardiac function by oesophageal stimulation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Autonomic disorders and their recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Anorexia, body composition, and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Serum hormones in men with human immunodeficiency virus-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Serum tumour necrosis factor-alpha levels in cancer patients are discontinuous and correlate with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Brain cytokine production and action in anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Cytokines and endotoxin induce cytokine receptors in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Xerostomia in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Determinants of the sensation of thirst in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Regulation of skeletal muscle protein turnover during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Bioelectrical impedance, cancer nutritional assessment, and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Body composition measurements during wasting diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Inter-rater reliability of formally trained and self-trained raters using the Edmonton Functional Assessment Tool

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

New developments in the assessment of pain in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effective communication skills are the key to good cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Patient preferences versus physician perceptions of treatment decisions in cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Clinical trial designs for cytostatic agents: are new approaches needed?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The patient with incurable aphagic cancer: to feed or not to feed?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Nutrition support in patients with cancer: what do the data really show?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Parenteral nutrition in patients receiving cancer chemotherapy. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Should cancer patients with incurable disease receive parenteral or enteral nutritional support?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Cachexia and asthenia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A review of the drug treatment of cachexia associated with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Tumor-associated gastroparesis: correction with metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The use of corticosteroids in the treatment of symptoms associated with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Corticosteroid therapy of preterminal gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Prednisolone as an appetite stimulant in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

On appetite and its loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Recent clinical experience with dronabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Thalidomide in patients with cachexia due to terminal cancer: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Current role of thalidomide in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Is there a role for melatonin in the treatment of neoplastic cachexia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Palliative medicine and medical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

IOM calls for improvements in palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

Constipation in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900011-4

7 January 2021

10.1016/S0889-8588(02)00011-4

Identifiers

DOI

1 reference

31 July 2017

1 reference